PH31213A - Drug for neuroprotection. - Google Patents

Drug for neuroprotection.

Info

Publication number
PH31213A
PH31213A PH48319A PH48319A PH31213A PH 31213 A PH31213 A PH 31213A PH 48319 A PH48319 A PH 48319A PH 48319 A PH48319 A PH 48319A PH 31213 A PH31213 A PH 31213A
Authority
PH
Philippines
Prior art keywords
neuroprotection
drug
Prior art date
Application number
PH48319A
Other languages
English (en)
Inventor
Shirasaki Yasufumi
Yamaguchi Hitoshi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of PH31213A publication Critical patent/PH31213A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
PH48319A 1993-05-25 1994-05-24 Drug for neuroprotection. PH31213A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12293393 1993-05-25

Publications (1)

Publication Number Publication Date
PH31213A true PH31213A (en) 1998-05-05

Family

ID=14848208

Family Applications (1)

Application Number Title Priority Date Filing Date
PH48319A PH31213A (en) 1993-05-25 1994-05-24 Drug for neuroprotection.

Country Status (10)

Country Link
US (2) US5661150A (no)
EP (1) EP0627219A1 (no)
CN (1) CN1100301A (no)
AU (2) AU684270B2 (no)
CA (1) CA2124284C (no)
FI (1) FI942400L (no)
NO (2) NO941915L (no)
PH (1) PH31213A (no)
RU (1) RU2135162C1 (no)
TW (1) TW309427B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2152941C1 (ru) * 1994-11-14 2000-07-20 Дайити Фармасьютикал Ко., Лтд. Кристаллический дигидрохлорид 3-[2-[4-(3-хлор-2-метилфенил)-1-пиперазинил]этил]-5,6-диметокси-1- (4-имидазолилметил)-1н-индазола и его 3,5-гидрат, способы их получения
CA2188816C (en) * 1996-04-23 2009-09-22 Takeda Chemical Industries, Ltd. Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein
US7202279B1 (en) 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
DE19820224A1 (de) * 1998-05-06 1999-12-09 Markus Schott Bindungspartner und Verfahren zur kompetitiven Hemmung der Bindung zwischen NEF-Protein und Calmodulin, sowie Mittel und Verwendung bei HIV-Erkrankungen
WO1999065500A1 (en) * 1998-06-17 1999-12-23 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
US6105582A (en) * 1998-07-28 2000-08-22 Pranevicius; Osvaldas Cerebral blood outflow maintenance during intracranial hypertension
WO2002010768A2 (en) * 2000-07-31 2002-02-07 The Regents Of The University Of California Model for alzheimer's disease and other neurodegenerative diseases
GB2377635B (en) * 2001-04-17 2005-10-19 Hoffmann La Roche Novel use of neuronal calcium sensor-1 (NCS-1) in therapy of CNS disorders and in the development of therapeutic agents
US20030032579A1 (en) * 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
WO2007062862A2 (en) * 2005-12-02 2007-06-07 Ludwig Maximilians Universität München Use of calmodulin inhibitors for the treatment of neurodegenerative disorders
WO2024018245A1 (en) 2022-07-22 2024-01-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of calpain inhibitors for the treatment of the diabetic kidney disease
WO2024153744A1 (en) 2023-01-20 2024-07-25 Institut National de la Santé et de la Recherche Médicale Autophagy activators for the treatment of rhabdomyolysis

Also Published As

Publication number Publication date
EP0627219A1 (en) 1994-12-07
NO941915L (no) 1994-11-28
TW309427B (no) 1997-07-01
NO941915D0 (no) 1994-05-24
FI942400A7 (fi) 1994-11-26
CN1100301A (zh) 1995-03-22
RU94017849A (ru) 1997-05-27
CA2124284C (en) 2002-10-01
US5837706A (en) 1998-11-17
CA2124284A1 (en) 1994-11-26
AU684270B2 (en) 1997-12-11
FI942400A0 (fi) 1994-05-24
NO993627L (no) 1994-11-28
RU2135162C1 (ru) 1999-08-27
NO993627D0 (no) 1999-07-26
US5661150A (en) 1997-08-26
FI942400L (fi) 1994-11-26
AU5837298A (en) 1998-05-21
AU6333194A (en) 1994-12-01

Similar Documents

Publication Publication Date Title
GR3029455T3 (en) 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives.
PH30879A (en) Incontience article for mates.
EP0620222A3 (en) Tetrahydro-beta-carbolines.
EP0641704A3 (en) One wheel sled.
EP0597463A3 (en) Thermotherapiesonde.
ZA934603B (en) thiazolylvinylphenyl derivatives.
EP0655256A3 (en) Inhaler.
EP0670716A4 (en) TASTE-MASKED PHARMACEUTICAL SUBSTANCES.
EP0580285A3 (en) Automatic reclosing.
EP0634459A3 (de) Formulierungen.
EP0620223A3 (en) Tetrahydropyridoindole.
ZA941137B (en) Substitutet azolone derivatives.
EP0633771A4 (en) Compounds.
EP0647707A3 (de) Thermokammer.
ZA946728B (en) Tocopherois.
AU6333194A (en) Drug for neuroprotection
ZA949333B (en) Methyl 3-methoxy 2-phenyl-acrylates.
EP0609763A3 (en) Ph-glasselectrode.
EP0657193A3 (de) Skibremse.
EP0599191A3 (en) Engine speed control circuit.
EP0641898A3 (de) Schachtabdeckung.
ZA9610589B (en) Pharmaceutical compounds.
EP0643916A3 (en) Choux blends.
EP0639673A3 (en) Support.
EP0645218A3 (de) Werkzeugschaft.